Brief: Evolent Health Q3 Revenue USD 479.533 Million Vs. IBES Estimate USD 467.5 Million
06/11/2025 21:10
Nov 06 (Reuters) - Evolent Health Q3 adjusted EBITDA USD 38.955 million. Q3 adjusted EBITDA margin 8.1% Q3 net income USD -26.93 million outlook Q4 adjusted EBITDA USD 30-40 million
Recent news on Evolent Health
See all newsEvolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows